Recent CIG Publications

01. Catheter 2

Full Study Title: Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban

Principal Investigator: Michael J. Kovacs

Study Publicationhttp://www.sciencedirect.com/science/article/pii/S0049384817302578?via%3Dihub

02. EPCAT II

Full Study Title: Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty

Principal Investigator: David Anderson

Funding: CIHR (Canadian Institutes of Health Research)

Design: Double-blind RCT (randomized clinical trial) of rivaroxaban vs. aspirin for total knee and total hip arthroplasty

For more information: NCT01720108 https://clinicaltrials.gov/

Study Publication: http://www.nejm.org/doi/full/10.1056/NEJMoa1712746

03. REVERSE II

Full Study Title: Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism

Principal Investigator: Marc Rodger

Funding: Funded by a grant from the French Ministry of Health (PHRC 2009-08-05) and BioMerieux

Study Publicationhttp://www.bmj.com/content/356/bmj.j1065

04. UPRATE

Full Study Title: Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study

Principal Investigator: Sam Schulman

Funding: Octapharma

Study Publication (Abstract): https://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1636541